A method for detecting alkaline phosphatase
The fluorescence emission spectrum of alkaline phosphatase was detected by using a combination of N-methylporphyrin dipropionate IX, G-tetramer and 4-nitrophenyl phosphate hexahydrate, and the detection in the prior art was solved The problems of low sensitivity and slow speed achieve high sensitivity and rapid alkaline phosphatase detection.
Patent Information
- Application Number
- CN202111138196.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2021-09-27
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2041-09-27
AI Technical Summary
The existing alkaline phosphatase detection methods have low sensitivity and slow detection speed, and there are limitations such as expensive reagents, long time, and complex synthetic routes.
Using the combination of N-methylporphyrin dipropionate IX, G-tetramer and 4-nitrophenyl phosphate hexahydrate, the fluorescence emission peak at 610 nm was detected, and the alkali was obtained by combining the standard equation. The concentration of phosphatase was detected using the fluorescence drop principle of G-tetramer and N-methylporphyrin dipropionate IX complex.
A method for high sensitivity and rapid detection of alkaline phosphatase is realized, with a detection limit of 0.81U/L, which has a fast detection speed and good linear correlation and selectivity for alkaline phosphatase.
Smart Images

Figure CN113758909B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of detecting alkaline phosphatase, and in particular to a method for detecting alkaline phosphatase. Background Art
[0002] Alkaline phosphatase (ALP) is widely present in human liver, bone, intestine, kidney, placenta and other tissues. Because it plays an important role in signal transduction, cell growth and apoptosis, it is often used as a marker for specific diseases, such as bile duct obstruction, abnormal liver function and renal osteodystrophy. Therefore, the detection of alkaline phosphatase levels is of great clinical significance.
[0003] Many methods for measuring alkaline phosphatase have been developed, including electrochemical methods, colorimetric methods, and fluorescence methods. Among them, the fluorescence method has attracted much attention due to its high sensitivity. Some fluorescent materials, such as nanoclusters, organic fluorophores, quantum dots, and carbon dots, have been successfully used to monitor alkaline phosphatase. However, most of these methods have limitations such as expensive reagents, long time, and complex synthesis routes. Based on this, it is necessary to develop a method for detecting alkaline phosphatase with high sensitivity and fast detection speed. Summary of the invention
[0004] The purpose of the present invention is to overcome the above technical deficiencies, provide a method for detecting alkaline phosphatase, and solve the technical problems of low sensitivity and slow detection speed of alkaline phosphatase in the prior art.
[0005] In order to achieve the above technical purpose, the technical solution of the present invention provides a method for detecting alkaline phosphatase, comprising the following steps:
[0006] S1, adding N-methylporphyrin dipropionic acid IX, G-tetramer and 4-nitrophenyl phosphate hexahydrate to a buffer solution, and then continuing to add a test solution to obtain a test system;
[0007] S2, detecting the fluorescence emission spectrum of the system to be tested and obtaining the fluorescence emission peak at 610 nm;
[0008] S3. Obtaining the concentration of alkaline phosphatase in the test solution according to the fluorescence emission peak combined with the standard equation of the concentration of alkaline phosphatase and the fluorescence emission peak.
[0009] Further, in step S3, the standard equation is Y=-62375.4834X+2028450, wherein X represents the concentration of alkaline phosphatase, and Y represents the fluorescence emission peak.
[0010] Further, in step S3, the standard equation is obtained by the following steps:
[0011] Alkaline phosphatase solutions of different known concentrations are added to a buffer solution containing N-methylporphyrin dipropionic acid IX, G-tetramer and 4-nitrophenyl phosphate hexahydrate disodium salt to react to obtain a mixture; the fluorescence emission spectrum of the mixture is detected and the fluorescence emission peak at 610 nm is recorded, and the standard equation is established according to the relationship between the concentration of the alkaline phosphatase solution and the corresponding fluorescence emission peak.
[0012] Further, in step S1, the sequence of the G-tetramer is 5'-GTGGGTCATTGTGGGTGGGTGTGG-3'.
[0013] Furthermore, in step S1, the concentration of the G-tetramer in the buffer is above 500 nM.
[0014] Furthermore, in step S1, the concentration of the 4-nitrophenyl phosphate hexahydrate in the buffer solution is above 500 μM.
[0015] Furthermore, in step S1, the pH of the buffer solution is 8-8.5.
[0016] Furthermore, the concentrations of the alkaline phosphatase solutions of different concentrations are 0U / L, 2.5U / L, 5U / L, 10U / L, 15U / L, 20U / L, 25U / L, 30U / L, 40U / L, and 60U / L, respectively.
[0017] Furthermore, in step S1, the test solution is added and mixed for 30-40 minutes, and then the reaction is continued at 36-37° C. to obtain the test solution.
[0018] Further, the reaction is continued at 36-37° C. for 30-40 minutes to obtain the test solution.
[0019] Compared with the prior art, the invention has the following beneficial effects: when alkaline phosphatase is not present, the G-tetramer and N-methylporphyrin dipropionic acid IX in the buffer solution form a complex to emit strong fluorescence (400nm excitation, 610nm emission). When alkaline phosphatase is present, 4-nitrophenyl phosphate hexahydrate in the buffer solution is hydrolyzed into p-nitrophenol, and then the energy of the 400nm fluorescence excitation is absorbed by p-nitrophenol, so the G-tetramer / N-methylporphyrin dipropionic acid IX complex cannot be excited, resulting in fluorescence decline, detecting the fluorescence emission spectrum of the system to be tested and obtaining the fluorescence emission peak at 610nm, and combining the concentration of alkaline phosphatase with the standard equation of the fluorescence emission peak to obtain the concentration of alkaline phosphatase in the test solution, the method has high sensitivity and fast detection speed. BRIEF DESCRIPTION OF THE DRAWINGS
[0020] Figure 1AIt is the UV-visible absorption spectrum of PNPP and PNP of the present invention.
[0021] Figure 1B is the fluorescence excitation spectrum of the G4 / NMM complex of the present invention.
[0022] Figure 2 This is a schematic diagram of the principle of detecting alkaline phosphatase based on G4 / NMM and the internal filtration effect on PNP in the present invention.
[0023] Figure 3 It is the fluorescence spectrum diagram under different conditions of Example 1 of the present invention.
[0024] Figure 4A This is a graph showing the fluorescence intensity results of G4 / NMM at 610 nm in Example 1 of the present invention.
[0025] Figure 4B This is a graph showing the effect of different amounts of PNPP on the fluorescence intensity of the G4 / NMM complex in Example 1 of the present invention.
[0026] Figure 4C This is a graph showing the effect of the pH value of the buffer solution in Example 1 of the present invention on the fluorescence intensity of the G4 / NMM complex.
[0027] Figure 5A It is a fluorescence spectrum diagram of ALP response to different concentrations in Example 1 of the present invention.
[0028] Figure 5B 1 is a graph showing the fluorescence signal results of different concentrations of ALP at 610 nm in Example 1 of the present invention, wherein the inset is a linear relationship graph of the fluorescence signal in the range of 2.5-25 U / L.
[0029] Figure 6 This is a diagram of the selectivity analysis results of the method in Example 1 of the present invention. DETAILED DESCRIPTION
[0030] This specific embodiment provides a method for detecting alkaline phosphatase (ALP), comprising the following steps:
[0031] S1. Add N-methylporphyrin dipropionic acid IX (i.e., NMM), G-tetramer (i.e., G4) and 4-nitrophenyl phosphate hexahydrate (i.e., PNPP) to a buffer solution, and then continue to add the test solution and mix for 30-40 minutes, and then continue to react at 36-37°C for 30-40 minutes to obtain a test system; the sequence of the G-tetramer is 5'-GTGGGTCATTGTGGGTGGGTGTGG-3'; the concentration of the G-tetramer in the buffer solution is above 500 nM; the concentration of the 4-nitrophenyl phosphate hexahydrate in the buffer solution is above 500 μM; the pH of the buffer solution is 8-8.5.
[0032] S2, detecting the fluorescence emission spectrum of the system to be tested and obtaining the fluorescence emission peak at 610 nm;
[0033] S3. Obtaining the concentration of alkaline phosphatase in the test solution according to the fluorescence emission peak combined with the concentration of alkaline phosphatase and the standard equation of the fluorescence emission peak; the standard equation is Y=-62375.4834X+2028450, wherein X represents the concentration of alkaline phosphatase and Y represents the fluorescence emission peak; the standard equation is obtained by the following steps:
[0034] Alkaline phosphatase solutions of different known concentrations are added to a buffer solution containing N-methylporphyrin dipropionic acid IX, G-tetramer and 4-nitrophenyl phosphate hexahydrate disodium salt to react and obtain a mixture; the fluorescence emission spectrum of the mixture is detected and the fluorescence emission peak at 610 nm is recorded, and the standard equation is established according to the relationship between the concentration of the alkaline phosphatase solution and the corresponding fluorescence emission peak; the concentrations of the alkaline phosphatase solutions of different concentrations are 0U / L, 2.5U / L, 5U / L, 10U / L, 15U / L, 20U / L, 25U / L, 30U / L, 40U / L and 60U / L, respectively.
[0035] The invention principle is as follows:
[0036] Combination Figure 2 , where G4 / NMM represents G-tetramer / N-methylporphyrin dipropionate IX complex, Alkalinephosphatase is alkaline phosphatase, PNPP is 4-nitrophenyl phosphate hexahydrate disodium salt, and PNP is p-nitrophenol. PNPP is the substrate of ALP, and the product p-nitrophenol (i.e., PNP) can be generated through the hydrolysis of ALP. Figure 1A As shown in the figure, PNPP has an absorption peak at 310nm. When PNP is generated, the maximum absorption peak moves to 400nm. Figure 1B As shown in Figure 3, the maximum excitation wavelength of G4 / NMM is exactly 400 nm. Therefore, the generated PNP can quench the fluorescence of G4 / NMM through the inner filter effect.
[0037] Through the analysis of the absorption spectrum of PNP and the excitation spectrum of G4 / NMM, we know that the maximum absorption peak of PNP is close to the maximum excitation peak of G4 / NMM. Based on this phenomenon, we designed a new fluorescence method for detecting ALP.
[0038] The detection principle is: when ALP is not present, G4 / NMM emits strong fluorescence (400nm excitation, 610nm emission). When ALP is added, PNPP is hydrolyzed into PNP. At this time, when excited with 400nm fluorescence, its energy is absorbed by PNP, so G4 / NMM cannot be excited, resulting in a decrease in fluorescence. In this process, since ALP plays the role of a catalyst, an ultra-sensitive ALP detection method can be established.
[0039] In order to make the purpose, technical solution and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not intended to limit the present invention.
[0040] Example 1
[0041] This embodiment includes the following steps: using an ELISA reader to scan the UV-visible absorption spectra of PNPP and PNP, the fluorescence excitation spectrum of G4 / NMM and study the feasibility of the method; using an ELISA reader to study the feasibility of the method; optimizing the G4 concentration, PNPP concentration, and buffer pH; the sensitivity and linear detection range of the method; the selectivity of the method; and real sample detection.
[0042] (1) Feasibility of research method
[0043] In order to evaluate the feasibility of our design, we first performed fluorescence spectral scanning on G4 / NMM (G4 sequence: 5'-GTGGGTCATTGTGGGTGGGTGTGG-3'), G4+NMM+PNPP, G4+NMM+PNP, and G4+NMM+PNPP+ALP. We prepared four groups of samples, namely 500nM G4+500nM NMM; 500nM G4+500nM NMM+500μMPNPP; 500nM G4+500nM NMM+500μM PNP; 500nM G4+500nM NMM+500μM PNPP+100U / L ALP. All of the above samples were reacted in pH=8 buffer (50mM HEPES, 0.5M NaCl) for 30 minutes. 200μL of each group of samples was added to a 96-well ELISA plate, and the changes in fluorescence signals were recorded using an ELISA instrument.
[0044] The results are as follows Figure 3As shown: The G4 / NMM complex exhibited strong fluorescence at 610 nm. When PNPP was added, the fluorescence was not affected. However, the addition of PNP could significantly inhibit the fluorescence. When ALP was added to the mixture of PNPP and G4 / NMM, fluorescence quenching could also be clearly observed due to the hydrolysis of PNPP to PNP. Therefore, these results indicate that the proposed method can be used to detect alkaline phosphatase.
[0045] (2) Optimization of reaction conditions
[0046] In order to achieve the best analytical performance of the alkaline phosphatase detection method, several experimental parameters involved in this experiment were optimized:
[0047] Since the fluorescence intensity of NMM will increase with the increase of G-tetramer concentration, the NMM concentration was fixed at 500nM to optimize the G-tetramer concentration. 100nM, 200nM, 300nM, 400nM, 500nM, 600nM, 700nM, 800nM G-tetramer and 500nM NMM were added to pH=8 buffer (50mM HEPES, 0.5M NaCl) and reacted for 30 minutes. 200μL of each sample was added to a 96-well ELISA plate, and the fluorescence signal changes were recorded with an ELISA instrument. The results are shown in Figure 2. Figure 4A As shown, the G-quadruplex concentration increased in the range of 100-800 nM, and the fluorescence intensity reached a plateau at 500 nM, indicating that NMM was completely bound by G4. Therefore, 500 nM G-quadruplex concentration was selected as the optimal concentration.
[0048] Since in the experiment, we must ensure that there are enough substrates PNPP and ALP to react, and we must also follow the principle of saving experimental materials, so we studied the effect of PNPP concentration on fluorescence quenching. When the concentration of ALP was fixed at 100U / L, PNPP with a concentration of 100-800μM was added to a buffer solution (50mM HEPES, 0.5M NaCl) containing 500nM G4 and 500nM NMM for 30 minutes. 200μL of each sample was added to a 96-well ELISA plate, and the fluorescence signal changes were recorded with an ELISA instrument. Figure 4B As shown in the figure, when the concentration reaches 500 μM, the fluorescence no longer decreases. Therefore, excess PNPP can no longer reduce the fluorescence intensity. Therefore, a concentration of 500 μM PNPP was selected as the optimal concentration.
[0049] Finally, considering the effect of buffer pH on fluorescence quenching, the buffer pH was optimized, such as Figure 4C As shown, when pH = 8.0, the fluorescence quenching effect is the best, so pH = 8.0 was selected for subsequent experiments.
[0050] (3) Sensitivity and linear detection range of the method
[0051] First, we added different concentrations of alkaline phosphatase to a buffer solution (50 mM HEPES, 0.5 M NaCl, pH = 8) containing 500 nM NMM, 500 nM G4, and 500 μM PNPP for 30 minutes, mixed thoroughly, and reacted at 37°C for 30 minutes. Finally, the spectral changes were recorded using an enzyme marker. Figure 5A As shown in the figure, within the concentration range of 0-30U / L, the fluorescence intensity decreases with the increase of ALP concentration, and then reaches a plateau. When the ALP concentration is increased, the fluorescence change is not obvious. Then, we analyzed the peak at 610nm, and the results are as follows Figure 5B As shown in the figure, within the range of 2.5-25 U / L, the fluorescence intensity has a good linear correlation with the ALP concentration. The calibration equation is Y = -62375.4834X + 2028450 (R 2 =0.995), X represents the concentration of alkaline phosphatase, and Y represents the fluorescence emission peak. According to 3 times the blank error / slope, the detection limit obtained from the calibration curve is 0.81 U / L.
[0052] (4) Selectivity of the method
[0053] By comparing the response of ALP with possible interfering substances in serum (BSA, glycine, glucose, Na + , K + , Ca 2+ , Fe 3+ Mg 2+ ) to study the selectivity of the biosensor we designed. BAS (bovine serum albumin) was used to study the interference of proteins. The results are shown in Figure 6 As shown in the figure, only ALP can produce a large fluorescence change, while other interfering substances are at the background level. It should be noted that F0 represents the fluorescence intensity without ALP, F represents the fluorescence intensity with ALP, and F0-F represents the difference between the two. These results show that this method has a high selectivity for the detection of ALP in serum.
[0054] (5) Detection of alkaline phosphatase in bovine serum samples
[0055] In order to evaluate the applicability and reliability of the proposed detection method in actual biological samples, the analytical performance of ALP determination was carried out in bovine serum. Before the measurement, the serum samples were treated with 10-fold dilution to reduce matrix interference. Then, different concentrations of ALP were added to the serum samples using the standard addition method. Finally, the content of alkaline phosphatase was determined using the detection method, and the recovery rate was calculated. As shown in Table 1, the recovery rates ranged from 90.46% to 98.90%, which demonstrated the reliability of the proposed detection method for detecting ALP in biological samples.
[0056] Table 1 Analysis of the recovery rate of alkaline phosphatase
[0057]
[0058] The specific implementation of the present invention described above does not constitute a limitation on the protection scope of the present invention. Any other corresponding changes and modifications made based on the technical concept of the present invention should be included in the protection scope of the claims of the present invention.
Claims
1. A method for detecting alkaline phosphatase, characterized in that: The following steps are involved: S1. Add N-methylporphyrin dipropionic acid IX, G-tetramer and 4-nitrophenyl phosphate hexahydrate to a buffer solution, and then continue to add a test solution to obtain a test system, wherein the concentration of the G-tetramer in the buffer solution is 500 nM or more, the concentration of the 4-nitrophenyl phosphate hexahydrate in the buffer solution is 500 μM or more, the sequence of the G-tetramer is 5'-GTGGGTCATTGTGGGTGGGTGTGG-3', the pH of the buffer solution is 8-8.5, and after adding the test solution, mix for 30-40 minutes, and then continue to react at 36-37° C. for 30-40 minutes to obtain the test solution; S2, detecting the fluorescence emission spectrum of the system to be tested and obtaining the fluorescence emission peak at 610 nm; S3. Obtain the concentration of alkaline phosphatase in the test solution according to the fluorescence emission peak combined with the concentration of alkaline phosphatase and the standard equation of the fluorescence emission peak. In step S3, the standard equation is Y=-62375.4834X+2028450, wherein X represents the concentration of alkaline phosphatase and Y represents the fluorescence emission peak. In step S3, the standard equation is obtained by the following steps: Alkaline phosphatase solutions of different known concentrations are added to a buffer solution containing N-methylporphyrin dipropionic acid IX, G-tetramer and 4-nitrophenyl phosphate hexahydrate disodium salt to react to obtain a mixture; the fluorescence emission spectrum of the mixture is detected and the fluorescence emission peak at 610 nm is recorded, and the standard equation is established according to the relationship between the concentration of the alkaline phosphatase solution and the corresponding fluorescence emission peak, and the concentrations of the alkaline phosphatase solutions of different known concentrations are 0 U / L, 2.5 U / L, 5 U / L, 10 U / L, 15 U / L, 20 U / L, 25 U / L, 30 U / L, 40 U / L, and 60 U / L, respectively.
Citation Information
Patent Citations
Fluorescence biosensor, preparation method, and application of fluorescence biosensor on detection of copper ion, pyrophosphate and alkaline phosphatase
CN107976427A
Application of aptamer in recognition and binding of alkaline phosphatase heterodimer or tumor detection
US20200362349A1
